Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 4
2007 2
2009 1
2012 5
2013 3
2014 5
2015 6
2016 2
2017 2
2018 2
2019 6
2020 9
2021 20
2022 15
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Characteristics and Outcomes of Fontan Versus Non-Fontan Patients Undergoing Combined Heart-Liver Transplantation: A Retrospective Cohort Study.
Wu WK, Siegrist KK, Ziogas IA, Mishra KL, Matsuoka LK, Menachem JN, Izzy M, Shingina A, Do NL, Bacchetta M, Shah AS, Alexopoulos SP. Wu WK, et al. Among authors: matsuoka lk. J Cardiothorac Vasc Anesth. 2024 Mar;38(3):745-754. doi: 10.1053/j.jvca.2023.11.043. Epub 2023 Dec 4. J Cardiothorac Vasc Anesth. 2024. PMID: 38172029
Effect of Previous Transarterial Chemoembolization on Survival and Toxicity after Yttrium-90 Transarterial Radioembolization of Hepatocellular Carcinoma in the Radiation-Emitting SIR-Spheres in Nonresectable Liver Tumor Registry.
Hund HC, Du L, Matsuoka L, Sze DY, Kennedy AS, Golzarian J, Gandhi RT, Collins ZS, Brown DB. Hund HC, et al. Among authors: matsuoka l. J Vasc Interv Radiol. 2023 Dec;34(12):2147-2154.e2. doi: 10.1016/j.jvir.2023.08.039. Epub 2023 Aug 30. J Vasc Interv Radiol. 2023. PMID: 37657500
Overall survival and toxicity of hepatocellular carcinoma Barcelona Clinic Liver Cancer B patients receiving Y90 radioembolization: analysis of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
Adeniran OR, Nguyen CN, Perez TH, Frantz SK, Matsuoka L, Du L, Gandhi RT, Collins ZS, Matrana MR, Petroziello M, Brower JS, Sze DY, Kennedy AS, Golzarian J, Wang EA, Brown DB. Adeniran OR, et al. Among authors: matsuoka l. J Gastrointest Oncol. 2023 Apr 29;14(2):874-885. doi: 10.21037/jgo-22-972. Epub 2023 Mar 6. J Gastrointest Oncol. 2023. PMID: 37201079 Free PMC article.
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Hund HC, Frantz SK, Wu H, Adeniran OR, Wong TY, Borgmann AJ, Matsuoka L, Geevarghese S, Alexopoulos S, Shingina A, Meranze SG, Baker JC, Garbett S, Brown DB. Hund HC, et al. Among authors: matsuoka l. J Vasc Interv Radiol. 2023 Mar;34(3):378-385. doi: 10.1016/j.jvir.2022.11.029. Epub 2022 Dec 5. J Vasc Interv Radiol. 2023. PMID: 36481322
Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C).
Goswami P, Adeniran OR, K Frantz S, Matsuoka L, Du L, Gandhi RT, Collins ZS, Matrana MR, Petroziello M, Brower JS, Sze DY, Kennedy AS, Golzarian J, Wang EA, Brown DB. Goswami P, et al. Among authors: matsuoka l. BMC Gastroenterol. 2022 Nov 17;22(1):467. doi: 10.1186/s12876-022-02528-y. BMC Gastroenterol. 2022. PMID: 36396989 Free PMC article.
Research Priorities in Percutaneous Image- and Endoscopy-Guided Interventions for Biliary and Gallbladder Diseases: Proceedings from the Society of Interventional Radiology Foundation Multidisciplinary Research Consensus Panel.
Riaz A, Trivedi P, Aadam AA, Katariya N, Matsuoka L, Malik A, Gunn AJ, Vezeridis A, Sarwar A, Schlachter T, Harmath C, Srinivasa R, Abi-Jaoudeh N, Singh H. Riaz A, et al. Among authors: matsuoka l. J Vasc Interv Radiol. 2022 Oct;33(10):1247-1257. doi: 10.1016/j.jvir.2022.06.025. Epub 2022 Jul 7. J Vasc Interv Radiol. 2022. PMID: 35809805
75 results